CoreCivic, Inc.

CoreCivic, Inc. (CXW) Market Cap

CoreCivic, Inc. has a market capitalization of .

No quote data available.

CEO: Patrick Swindle

Sector: Real Estate

Industry: REIT - Specialty

IPO Date: 1997-07-15

Website: https://www.corecivic.com

CoreCivic, Inc. (CXW) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

CoreCivic, Inc. owns and operates partnership correctional, detention, and residential reentry facilities in the United States. It operates through three segments: CoreCivic Safety, CoreCivic Community, and CoreCivic Properties. The company provides a range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address America's recidivism crisis, and government real estate solutions. Its correctional, detention, and residential reentry facilities offer rehabilitation and educational programs, including basic education, faith-based services, life skills and employment training, and substance abuse treatment. As of December 31, 2021, the company owned and operated 46 correctional and detention facilities, 26 residential reentry centers, and 10 properties for lease. The company was founded in 1983 and is based in Brentwood, Tennessee.

Analyst Sentiment

83%
Strong Buy

From 4 Active Polls

1Y Forecast: $15.50

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$14

Median

$16

High Bound

$17

Average

$16

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$15.50
▼ -33.22% Upside
Low Target
$14.00
-40% Risk
Median Target
$15.50
-33% Mid
High Target
$17.00
-27% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CORECIVIC REIT INC (CXW) — Investment Overview

🧩 Business Model Overview

CORECIVIC REIT Inc. owns and finances real estate used for correctional and detention facilities and monetizes these assets through long-term arrangements with the parties that operate and/or procure governmental detention capacity. The value chain is rooted in (1) facility ownership and capital planning, (2) facility readiness and compliance, and (3) contract structure that converts expensive, operationally complex government demand into recurring lease and/or occupancy-linked cash flows. Because detention capacity is safety- and compliance-driven and procurement cycles are lengthy, the model depends on maintaining approved, operationally capable facilities rather than selling “one-off” services.

💰 Revenue Streams & Monetisation Model

The primary revenue engine is contract-backed utilization of detention capacity. Cash generation is typically supported by a mix of:

  • Recurring lease/occupancy-linked revenues that tie facility income to contracted or government-requested usage (reducing pure volume risk versus purely transactional models).
  • Government contracting economics where contract terms and renewal cadence shape the stability of cash flows.
  • Asset-level monetisation through ongoing facility operations and maintenance obligations that are contractually underpinned by the need for continuous compliance and readiness.

Margin dynamics are largely driven by operating pass-through structures, the ability to keep facilities compliant with evolving standards, and the durability of contract terms (including occupancy assumptions and lease protections). Capital intensity at the asset level also influences the long-run return profile through maintenance capex requirements and lease renewal economics.

🧠 Competitive Advantages & Market Positioning

CORECIVIC’s competitive edge is anchored in contractual and regulatory switching costs plus facility-readiness moats. Competitors can build new capacity, but replacing an approved, operationally compliant facility quickly is difficult because procurement requires extensive vetting, security capability alignment, staffing/operations integration, and compliance history.

  • Switching Costs / “Approval Moat”: Government counterparties face significant execution risk in swapping detention capacity providers mid-cycle. Facilities that are already integrated into contracting and compliance frameworks are harder to replace.
  • Regulatory/Operational Barriers: Correctional and detention environments demand strict adherence to security, reporting, and safety requirements, raising the hurdle for new entrants and limiting rapid capacity redeployment.
  • Asset Scale and Portfolio Management: A diversified footprint across contract types can smooth utilization volatility and support better capital planning for facility upgrades.

Competitive benchmarking: primary named peers include GEO Group (GEO), Management & Training Corporation (MTC), and Serco (government services with detention/corrections-related exposure depending on contract scope). In contrast to pure geographic concentration or diversified government services, the peer set competes on recognized facility ownership/operations capability and contracting relationships. Where MTC and GEO typically compete directly on correctional and detention capacity procurement, CORECIVIC’s positioning emphasizes facility readiness and long-duration contracting structures that can preserve utilization economics when demand is policy-driven and capacity-constrained.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by a combination of demand-driven secular factors and capacity modernization:

  • Structural demand for detention/corrections capacity: Government capacity needs arise from immigration enforcement cycles, court processing, and criminal justice system throughput—creating a persistent need for ready facilities.
  • Capacity constraints and lead times: Building or converting facilities requires planning, permitting, and compliance approvals that can extend beyond typical political or procurement cycles. This lag can favor established providers with pre-approved capacity.
  • Facility modernization requirements: Evolving safety and compliance standards incentivize capital redeployment and upgrades at existing facilities, supporting renewal economics for capable asset portfolios.
  • Long-duration contracting behavior: When contracts are structured with multi-year terms and renewal windows, utilization becomes more predictable, improving long-range cash flow visibility.

⚠ Risk Factors to Monitor

  • Policy and procurement risk: Changes in immigration enforcement priorities, sentencing practices, or contracting rules can shift detention demand and contract economics.
  • Contract renewal and pricing risk: Even with recurring frameworks, renewals may be competed, re-priced, or restructured based on political and budgetary conditions.
  • Regulatory and litigation risk: Heightened scrutiny around detention conditions, compliance, and reporting can drive cost increases, operational constraints, or reputational impacts that influence contract outcomes.
  • Capital intensity and maintenance capex: Correctional facilities require continuous upgrades to meet evolving standards; insufficient maintenance can impair renewal attractiveness.
  • Concentration risk: Exposure to specific contract types, governmental counterparties, or geographic/operational clusters can amplify downside if demand shifts.

📊 Valuation & Market View

Markets typically value correctional/detention REIT-like models through cash-flow durability rather than short-term earnings, with emphasis on:

  • Lease/contract length and renewal visibility (quality of contracted cash flows).
  • Utilization and occupancy assumptions (how demand translates into facility income).
  • Cash flow coverage metrics relevant to REIT distribution capacity (e.g., AFFO-style measures in sector analysis).
  • Cost of capital and refinancing conditions (capital-intensive asset bases are sensitive to interest rates and credit spreads).

Key valuation drivers are therefore the perceived stability of contracted utilization, the ability to protect margins through compliance-driven cost control, and the market’s view on the durability of policy-driven demand.

🔍 Investment Takeaway

CORECIVIC’s long-term thesis rests on facility-readiness and contracting switching costs: once detention capacity is approved, integrated, and supported by compliant operations, replacing that capability is operationally and procedurally difficult for government counterparties. The investment case hinges on the balance between (1) policy-driven demand persistence and renewal durability and (2) the company’s discipline in maintaining compliance, controlling contract economics, and financing required capital expenditures.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"Headline (2026-03-31, Q1): Revenue $614.7M, Net Income $37.9M (EPS $0.37). YoY: Revenue +25.8% and Net Income +51.0%. QoQ (vs 2025-12-31): Revenue +1.8% and Net Income +42.9%. Profitability improved across the quarter. Gross margin rose to 23.9% from 22.2% QoQ and 23.3% YoY. Operating margin also expanded to 16.8% (vs 14.8% QoQ; 9.7% YoY), while net margin increased to 6.2% (vs 4.4% QoQ; 5.1% YoY). This drove operating income to $103.3M, up strongly both QoQ and YoY. Cash flow quality looks mixed but improved on a free-cash-flow basis for the quarter: Operating cash flow was $13.8M and free cash flow was $13.8M (no PPE capex shown in the quarter). The company continued aggressive buybacks (repurchased $55.1M in Q1 2026) with no dividends paid. Balance sheet resilience is solid on equity: total assets rose to $3.37B QoQ and equity was roughly stable at $1.40B. Leverage appears elevated historically but decreased from the prior quarter as net debt turned negative (net debt -$209.7M), indicating improved liquidity. Total shareholder returns: shares are up YTD (+7.5%) and up over 6 months (+15.3%), but down over 1 year (-6.8%); no >20% momentum signal is present."

Revenue Growth

Good

Q1 2026 Revenue $614.7M: +1.8% QoQ (vs $603.95M) and +25.8% YoY (vs $488.63M). Momentum strengthened vs last year.

Profitability

Good

Margins expanded: gross margin 23.9% vs 22.2% QoQ and 23.3% YoY; operating margin 16.8% vs 14.8% QoQ and 9.7% YoY; net margin 6.2% vs 4.4% QoQ and 5.1% YoY.

Cash Flow Quality

Neutral

Net Income increased to $37.9M, but Operating Cash Flow was $13.8M (lower conversion). No dividends; buybacks of $55.1M continued. Free cash flow was positive at $13.8M for the quarter.

Leverage & Balance Sheet

Positive

Total assets increased to $3.37B. Equity was stable around $1.40B. Net debt improved materially to -$209.7M vs +$1.11B in Q4 2025 (liquidity improved), indicating resilience.

Shareholder Returns

Positive

Price is +7.5% YTD and +15.3% over 6 months, but -6.8% over 1 year (no strong 1y momentum). Capital returns via buybacks ($55.1M in Q1) support total return.

Analyst Sentiment & Valuation

Fair

Consensus price target $15.5 vs current $20.45 implies downside versus targets. Valuation looks demanding on earnings/FCF multiples (as reflected in provided ratios).

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

CoreCivic’s Q1 2026 results beat expectations, driven by EBITDA expansion from activating previously idle facilities under new ICE management contracts and from FarmVille (acquired July 1, 2025). Adjusted EPS was $0.40 (+74% YoY) and adjusted EBITDA $110.1M (+36% YoY), with upside of $0.12 and $13.3M vs analyst estimates, respectively. The key offset is transitory ICE demand volatility tied to the late-January to early-April DHS/government-shutdown environment: ICE detention populations fell roughly 3,000 for the company from peak levels, and management expects Q2 to reflect removal of $0.06 per share employee retention credits plus an additional $0.05-$0.07 per share ICE-related headwind. Management raised full-year guidance (adjusted EBITDA $453.8M-$461.8M; adjusted EPS $1.53-$1.63), largely supported by CSP acquisition (FY revenue $215M-$230M; $0.03-$0.05 EPS contribution) and the Midwest Regional Reception Center incremental $0.05-$0.06 per share. Liquidity remains adequate post-deal via $100M incremental term loan.

AI IconGrowth Catalysts

  • Activation of five previously idle facilities under new ICE management contracts since 2025 (4 facilities since 2025 plus Midwest Regional Reception Center reactivated in March 2026).
  • FDA-style expansion of capacity via new ICE facility contracts: West Tennessee Detention Center (stabilized), California City Detention Facility (contract effective Sept 1, 2025), Diamondback Correctional Facility (contract effective Sept 30, 2025).
  • Midwest Regional Reception Center special use permit approval (early March 2026) enabling incremental earnings of $0.05 to $0.06 per share for remainder of 2026.
  • Clinical Solutions Pharmacy (CSP) acquisition to diversify revenue in correctional mail-order pharmacy; 50% automated shipments, ~60,000 prescriptions/day.
  • State-level per diem increases and population growth (Georgia, Montana, Colorado) and consolidation/expansion into Tallahatchie County Correctional Facility to create marketable capacity for Arizona.

Business Development

  • ICE strategy discussion around desire to own certain assets for turnkey-managed detention facilities nationally (management contract duration and pricing would adjust accordingly).
  • U.S. Marshals Service: population declines partially offsetting ICE growth (shared contracts affect mix and timing).
  • CSP partnership/customer base: CSP serves over 600 correctional facilities across 28 states; CoreCivic becomes a CSP customer and CSP serves CoreCivic and others.
  • Leavenworth City Commission collaboration enabling special use permit approval for Midwest Regional Reception Center.

AI IconFinancial Highlights

  • GAAP EPS: $0.38; FFO per share: $0.64.
  • Adjusted EPS: $0.40 vs $0.23 prior year (+74%); exceeded average analyst estimates by $0.12.
  • Adjusted EBITDA: $110.1M vs $81.0M prior year (+36%); exceeded average analyst estimates by $13.3M.
  • Adjusted EBITDA growth drivers: activation of four previously idle facilities under new management contracts with ICE and acquisition of Farmville Detention Center (July 1, 2025).
  • Operating margin (Safety + Community combined): 24% vs 23.6% prior year (ex-retention-credit operating margin: 23% both quarters).
  • Employee retention credits under CARES Act: $4.6M increase in Q1 2026 vs Q1 2025; Q2 modeling assumes a $0.06 per share decline vs Q1 due to removal of Q1 credits.
  • Guidance EPS and EBITDA raised: diluted EPS $1.51-$1.61; adjusted diluted EPS $1.53-$1.63; adjusted EBITDA $453.8M-$461.8M (up from $437M-$445M).
  • ICE population headwind: updated guidance includes lower ICE-driven EPS impact of -$0.09 to -$0.15 per share from lower ICE populations vs prior forecast.
  • CSP acquisition expected to contribute $0.03 to $0.05 per share net of interest incurred.

AI IconCapital Funding

  • Share repurchases: 2.3M shares for $44.7M in Q1 2026 (authorized in 2022; total 28.1M shares repurchased for $444.2M through Mar 31, 2026).
  • Remaining board authorization: $255.8M as of Mar 31, 2026.
  • Leverage: net debt to adjusted EBITDA at 2.8x (TTM ended Mar 31, 2026).
  • Liquidity: $209.7M cash on hand; $131.3M borrowing capacity on revolver with $425M outstanding; total liquidity ~$341M.
  • Clinical Solutions Pharmacy acquisition: initial purchase price $148M (ex-transaction expenses) funded with cash + revolver borrowings.
  • Financing: April 10, 2026 incremental $100M term loan (364-day maturity; prepayable without penalty) to replenish revolver borrowings.

AI IconStrategy & Ops

  • Occupancy in Safety + Community: 79.6% (+2.6 points YoY).
  • Average daily population: 57,243 vs 51,429 YoY (increase driven by demand, new contracting, FarmVille acquisition).
  • ICE population management: peaked in January 2026; declined ~3,000 by end of April 2026 due to government shutdown effects and ICE agent redeployment; management views as temporary and event-specific.
  • Midwest Regional Reception Center SUP legal challenge caused a temporary delay in intake; facility began accepting detainees after SUP approval in early March 2026.
  • Maintains five idle corrections/detention facilities totaling ~7,000 beds (7,066 beds remaining per guidance) for incremental federal/state demand.

AI IconMarket Outlook

  • Updated FY 2026 diluted EPS: $1.51-$1.61 (vs $1.49-$1.59 prior); adjusted diluted EPS: $1.53-$1.63 (vs $1.49-$1.59 prior).
  • FY 2026 FFO per share: $2.58-$2.68; normalized FFO per share: $2.60-$2.70 (up from $2.54-$2.64).
  • FY 2026 adjusted EBITDA: $453.8M-$461.8M (up from $437M-$445M).
  • Q2 per-share modeling: -$0.06 due to removal of Q1 employee retention credits; -$0.05 to -$0.07 from lower ICE populations (aside from activations); partially offset by seasonality (+$0.01-$0.02).
  • Midwest Regional Reception Center incremental EPS: $0.05-$0.06 for remainder of 2026 included in updated guidance.
  • CSP acquisition: in for a full quarter beginning April 1; FY 2026 CSP revenue $215M-$230M and EPS contribution $0.03-$0.05 (net of acquisition financing interest).

AI IconRisks & Headwinds

  • Near-term ICE detention population reduction: ~10,500 decline nationally by early April 2026, with management projecting Q2 to sustain roughly around the lower range before Q3/Q4 growth under existing contracts.
  • Government shutdown/DHS reorganization and ICE agent redeployment to TSA checkpoints creating transitory enforcement-driven demand volatility.
  • U.S. Marshals Service population decline: average daily Marshals population down 1,360 vs Q1 2025; could further offset ICE growth due to shared-contract mix effects.
  • Trousdale facility transition: revenue decline expected to recover in coming quarters.
  • Uncertainty around future DHS detention bed strategies (warehouse conversions vs turnkey facility acquisitions) and potential contract timing on new awards not included in guidance.
  • Legal timing risk for SUP matters (Midwest Regional Reception Center intake delay) though guidance now includes contribution.

Q&A: Analyst Interest

  • ICE asset sales/valuation: Management explained ICE’s interest in owning turnkey assets, but said there is no true public comp due to special-purpose, highly improved detention properties. They value via depreciated replacement cost and would consider sales contingent on derived value and long-term management contract duration.
  • Q2 run-rate bridge from guidance: Management quantified Q1-to-Q2 bridge as roughly a $0.06 per share decline from removal of Q1 employee retention credits plus ICE population reductions of about $0.05 to $0.07 per share, partially offset by seasonality (one extra day in Q2 and unemployment tax seasonality).
  • CSP synergy and growth outlook: Management stated CSP is a standalone subsidiary with limited operating synergies, but highlighted potential administrative benefits like ERP consolidation and customer-related revenue synergies from overlapping correctional customers. They would not disclose exact growth rate; guidance-implied five-year CAGR is just over 10%, with CSP’s growth potential considered at least twice that.

Sentiment: MIXED

Note: This summary was synthesized by AI from the CXW Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — CoreCivic, Inc. (CXW) Financial Profile